|

anti-CD19/BCMA-UCAR-T cells Clinical Trials

1 actively recruiting trial

Top Sponsors

  • The First Affiliated Hospital with Nanjing Medical University1

Indications

  • Systemic Sclerosis1
  • Systemic Lupus Erythematosus1
  • Dermatomyositis1
  • Lupus1
  • Arthritis1

Other1 trial

Exploratory Clinical Study of Anti-CD19/BCMA Universal CAR-T Cell Injection for the Treatment of Refractory Autoimmune Diseases
N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.